AnaSpec Introduces Two New SensoLyte® Cathepsin L Assay Kits

AnaSpec is pleased to announce the release of two new SensoLyte® assay kits for the measurement of Cathepsin L activity – the SensoLyte® 520 and Rh110 Cathepsin L Assay Kits. The former utilizes a FRET (fluorescent resonance energy transfer)-based peptide substrate and the latter, a... - February 09, 2013 - AnaSpec, EGT Group

GenScript Launches eBlot® Protein Transfer System

GenScript USA Incorporation has launched the eBlot® Protein Transfer System, a semi-dry electric blotter for transferring proteins from mini polyacrylamide gels onto membranes in 7 to 10 minutes, expanding its bench-top tool offerings for protein analysis. This system simplifies the process further by including a complete line of accessories, eliminating the need for additional buffers. - February 07, 2013 - GenScript USA Inc.

GenScript Launches New PolyExpress Package

With the completion of an extensive new animal facility and validation of ground-breaking new immunization protocols, GenScript is able to offer this new antibody package at a staggeringly fast delivery time of just 45 days, 2 months faster than traditional immunization methods. - February 03, 2013 - GenScript USA Inc.

ProteinSignal - A New Brand of GenScript, Focused on Protein Research

ProteinSignal will serve as a pioneering developer and supplier of high performance protein research products covering the entire protein analysis workflow. Their offerings include cytokines and growth factors, protein purification resins, precast PAGE gels, protein standards, gel staining systems, anti-tag antibodies, western blot detection, ELISA kits and endotoxin detection and removal kits. - January 27, 2013 - GenScript USA Inc.

AnaSpec Offers a Wide Selection of SYBR® qPCR MasterMixes and Core Kits

AnaSpec, EGT Group offers a wide selection of SYBR® Green-based MasterMixes and Core Kits for almost any thermocycler available in the industry. - January 12, 2013 - AnaSpec, EGT Group

Wescadia Group’s BioDeal 360™: Analysis of Deal Activity in the Australian Life Science Sector

Wescadia Group, a healthcare consultancy firm, announces the release of its report “BioDeal 360™”. The report provides strategic analysis, commentary, insight, and opinion on selected deals in the Australian life science industry in 2012. - December 19, 2012 - Wescadia Group Pty Ltd

Highly Sensitive SensoLyte® HDACs and HATs Assay Kits for Epigenetics Research

AnaSpec has developed a series of highly sensitive assay kits for the detection of the activities of HDAC (Histone Deacetylase), SIRT (Sirtuin) 1 & 2 or HAT (Histone Acetyltransferases). - December 07, 2012 - AnaSpec, EGT Group

AnaSpec Introduces SensoLyte® ThT Aβ42 & Aβ40 Aggregation Kits

AnaSpec has developed the SensoLyte® ThT Aß40 and Aß42 Aggregation kits to provide a convenient and standard method for measurement of Aß40 and Aß42 aggregation, respectively. - December 06, 2012 - AnaSpec, EGT Group

BASF is Honored by Habitat for Humanity

BASF Named 2012 Sponsor of the Year by Habitat for Humanity - November 09, 2012 - BASF Corporation

BASF Donates $1,000 to Penrickton Center for Blind Children

BASF Wyandotte donates to Penrickton Center for Blind Children, located in Taylor, Michigan. - October 27, 2012 - BASF Corporation

OsoBio Appoints Alan P. Heim as Vice President of Human Resources

OSO BioPharmaceuticals Manufacturing, LLC, has appointed Alan P. Heim as vice president of human resources. In his capacity, Heim administers all policies and programs that affect personnel at OsoBio, including issues such as organizational planning; recruitment, hiring and training; employee... - October 05, 2012 - OSO BioPharmaceuticals Manufacturing, LLC

SignaBlok Awarded NCI Grant to Test New Approach to Lung Cancer Treatment

SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Cancer Institute (NCI) to develop novel and first-in-class agents in lung cancer. - October 03, 2012 - SignaBlok, Inc.

New Product Launch - Green Leaf Labs

Before the end of 2012 new N-(2-Hydroxyethyl) hexadecanamide products will be available worldwide with updated product specifications. - September 12, 2012 - Green Leaf Labs

AnaSpec Introduces SensoLyte® Enterokinase Assay Kits

AnaSpec, EGT Group is pleased to announce the release of two assay kits for quantitating enterokinase enzymatic activity – the SensoLyte® 520 and SensoLyte® Rh110 Enterokinase Activity Assay Kits. The former is a FRET (fluorescence resonance energy transfer)-based assay employing a... - August 30, 2012 - AnaSpec, EGT Group

AnaSpec Highlights Speedy 28-Day Custom Polyclonal Antibody

When traditional protocols can take 70+ days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec, EGT Group asked, "Is there a way to develop custom antibodies faster without sacrificing quality in the finished product?" Here's the answer. The Speedy... - August 24, 2012 - AnaSpec, EGT Group

AnaSpec Offers Phosphospecific Antibodies Production

Cellular phosphorylation is a reversible, covalent modification of a protein or lipid that results in the modification of the activity of the phosphorylated molecule by inducing small conformational changes within the molecule.1-2 Catalyzed by protein kinases, phosphate groups can be added via the... - August 17, 2012 - AnaSpec, EGT Group

AnaSpec Highlights Beta-Amyloid (1-40) Peptides

ß-Amyloid (1-40) together with ß-Amyloid (1-42) are two major C-terminal variants of the Aß protein constituting the majority of Aßs, with Ab (1-42) being more neurotoxic. These undergo post-secretory aggregation and deposition in the Alzheimer’s diseased... - August 01, 2012 - AnaSpec, EGT Group

AnaSpec Highlights Beta-Amyloid (1-42) Peptides

Harnessing over a decade's worth of experience and a multi-level technology platform that includes peptides, antibodies, dyes and assay kits, AnaSpec, EGT Group is one of the world's most trusted sources of integrated proteomic solutions specifically designed for Alzheimer's Disease... - July 25, 2012 - AnaSpec, EGT Group

SignaBlok Awarded NIH Grant to Develop New Nanotechnology for Diagnostic Imaging of Atherosclerosis

SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Institutes of Health (NIH) to develop multifunctional nanoformulations for diagnostic imaging of atherosclerosis. - July 12, 2012 - SignaBlok, Inc.

AnaSpec Introduces SensoLyte® Beta-Amyloid ELISA Kits

AnaSpec, EGT Group is pleased to announce the release of the SensoLyte® ELISA kits for the quantification of human and mouse/rat β-Amyloid (1-40) or (1-42) peptide. Compared to similar kits in the industry, these kits are a one-step assay optimized to detect human or mouse/rat beta-Amyloid... - June 29, 2012 - AnaSpec, EGT Group

AnaSpec Offers PTM Peptide Synthesis

Proteins undergo post-translational modifications (PTM) as a mechanism to expand the coding capacity of genes.1 PTMs found in histone “tails” (amino termini) such as acetylation, methylation and phosphorylation affect chromatin structure and exquisitely regulate gene... - June 27, 2012 - AnaSpec, EGT Group

AnaSpec Offers Industry’s Longest Wavelength Assay Kit for HDAC Dectection

Current HDAC assay kits have been based on a short wavelength substrate whose detection is darkened by the presence of autofluorescence interference. SensoLyte® has ushered in the dawn of ultra-sensitivity. AnaSpec, EGT Group’s SensoLyte® 520 HDAC Activity Assay Kit is the... - June 20, 2012 - AnaSpec, EGT Group

GenScript Launches a Premier Gene Synthesis Service "Gene-Bricktm" for Building Large DNA FragmentsTM

The Gene-BrickTM premier gene synthesis service is specifically designed to meet demands of large DNA fragments which are used in synthetic biology research, such as the building of large genetic circuits and synthetic chromosomes. - June 14, 2012 - GenScript USA Inc.

Inventys Research Butibori (Nagpur) Plant, Achieves ISO 9001:2008, ISO 14000:2004, and ISO 18000:OSHAS Certification

Inventys Research Butibori (Nagpur) Plant, Achieves ISO 9001:2008, ISO 14000:2004, and ISO 18000:OSHAS Certification

Inventys Research Company has achieved ISO 9001:2008, 14001:2004 and 18000:OSHAS Management System accreditation. The ISO 9001:2008 certification of compliance recognizes that the policies, practices, and procedures of Inventys ensure consistent quality in the products and services Inventys... - June 13, 2012 - Inventys Research Company Pvt Ltd.

AnaSpec Offers Anti-5-Methylcytidine (Clone 33D3)

AnaSpec, EGT Group is pleased to offer Eurogentec’s popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. Purified from ascites, this IgG1 / λ isotype antibody is supplied as a 1 mg/ml solution (in PBS) and is available in three sizes (0.1 mg,... - June 06, 2012 - AnaSpec, EGT Group

Royal Care Pharmacy (RCP) Joins PCCA

RCP is pleased to announce PCCA membership. - May 31, 2012 - Royal Care Pharmacy Inc

AnaSpec Offers a Wide Selection of GO® Histone Peptides

AnaSpec, EGT Group offers a wide selection of GO® (catalog) Histone peptides that are biotin-labeled. Single or combinations of post-translational modified (PTM) amino acid-containing biotinylated histone peptide sequences have been used in applications such as pull-down assays.1-2 Generally... - May 31, 2012 - AnaSpec, EGT Group

AnaSpec Showcases Fluorescent Nucleic Acid Probes

The detection of nucleic acids is important for many life science research tasks, such as sequencing, cDNA synthesis and cloning, RNA transcription and transfection. Accurate detection of DNA/RNA is key to the success of these techniques. DNA/RNA concentration is often measured by UV absorbance at... - May 19, 2012 - AnaSpec, EGT Group

AnaSpec Offers PEGylated Peptides Synthesis

PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple modification of a drug with polyethylene glycol (PEG) not only is capable of improving the drug’s solubility, diminishing the potential for aggregation, and... - May 16, 2012 - AnaSpec, EGT Group

Grand Rounds at Metropolitan Hospital - Compounding Options in Medicine: Special Focus on Physiatry

Dr Haldey, PharmD, President of Royal Care Pharmacy, Inc, will provide a comprehensive overview of pharmacy compounding with a specific focus on physiatry. - May 12, 2012 - Royal Care Pharmacy Inc

Royal Care Pharmacy Will Present at the 5th Annual Wound Symposium

Dr Emil Haldey, the Company’s President, has been invited to speak at the 5th Annual Wound Care Symposium sponsored by NY College of Podiatric Medicine and Nassau University Medical Center. Dr Emil Haldey will discuss history, rationale and benefits of pharmacy compounding for the modern podiatry practice. - May 12, 2012 - Royal Care Pharmacy Inc

AnaSpec Highlights SensoLyte® 520 Renin Assays for Human, Mouse & Rat Specific

AnaSpec, EGT Group, the provider of the ultra-sensitive SensoLyte® 520 Human Renin Assay Kit also provides renin kits specific for mouse and rat - the SensoLyte® 520 Mouse Renin Assay Kit and SensoLyte® 520 Rat Renin Assay Kit. Using proprietary 5-FAM/QXL™ 520 fluorescence... - May 09, 2012 - AnaSpec, EGT Group

OSO BioPharmaceuticals Invests $5 Million in Aseptic Filling Suite

State-of-the-art line will increase capacity and yield of liquid, suspension and lyophilized products. - May 02, 2012 - OSO BioPharmaceuticals Manufacturing, LLC

AnaSpec Introduces Pancreatic β-Cells Specific Antibodies - Anti-hFXYD2γa

AnaSpec, EGT Group is pleased to announce the release of three antibodies (two monoclonal and one polyclonal) against FXYD2γa. FXYD2γa is a regulating subunit of the NA+-K+-ATPase and has been identified as a unique and specific pancreatic beta cell surface biomarker. In individuals... - April 19, 2012 - AnaSpec, EGT Group

RayBiotech, Inc. and Innopsys Announce Co-Marketing Partnership

RayBiotech, Inc. today announced that it has entered into a co-marketing partnership with Innopsys of Carbonne, France to promote the sales of RayBiotech’s G-Series and Quantibody series of antibody arrays and array testing services with Innopsys’ Innoscan laser microarray scanning... - April 13, 2012 - RayBiotech, Inc

AnaSpec Highlights HiLyte Fluor™ Dyes Collection for Labeling Amine and Thiol-Modified Oligos

AnaSpec is pleased to highlight their wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides. Fluorescent dye-labeled oligos are widely used as... - March 29, 2012 - AnaSpec, EGT Group

World Leaders to Address Challenges and Technology Breakthroughs in Sample Preparation for Pathogen Detection at 5th Sample Prep Conference in San Diego, May 3-4

Leading organizations from around the world will convene in San Diego for the Knowledge Foundation’s 5th Sample Prep conference which will take place at the Hilton Resort & Spa from May 3-4, 2012. - March 24, 2012 - Knowledge Foundation

AnaSpec Develops AMC Resins for SPPS

Peptide-7-amino-4-methylcoumarin conjugates (peptide-AMCs) are widely used as fluorogenic substrates to study proteases. The preparation of peptide-AMCs usually involves solution phase synthesis since AMC lacks an additional functional group for attachment to a solid support. Although solid-phase... - March 22, 2012 - AnaSpec, EGT Group

CPC Scientific Announces Its Peptide Facility Passes 2nd Successful FDA Inspection

CPC Scientific is pleased to announce that its 50,000 sf cGMP peptide facility has successfully passed a second US Food and Drug Administration (FDA) inspection. It involved the investigator inspecting CPC Scientific’s peptide production facilities, manufacturing processes, laboratory control... - February 27, 2012 - CPC Scientific

AnaSpec Offers Symmetric & Asymmetric Dimethylated Arginine in Histone Peptides Collection

AnaSpec, EGT Group offers one of the world’s largest selections of Histone GO® (catalog) peptides. The peptides include sequences containing modified amino acids such as methylated (Me1, Me2 and Me3) Lysine; phosphorylated Threonine (pThr) or Serine (pSer); deiminated Arginine (Cit). - February 23, 2012 - AnaSpec, EGT Group

OsoBio Appoints Marian Meyer Director of Labs

Meyer manages the company’s chemistry and microbiology labs, which are responsible for such quality-control services as materials testing and release, environmental monitoring and analytical methods compliance. - February 23, 2012 - OSO BioPharmaceuticals Manufacturing, LLC

AnaSpec Offers Special Pricing for MOG (1-125) Recombinant Proteins

AnaSpec, EGT the first provider of commercial MOG recombinant proteins is pleased to offer a 50% discount off on MOG (1-125) recombinant proteins through the month of February, 2012 to US and Canadian customers. Please mention code “rMOG50%” when ordering to get the discount. AnaSpec's... - February 16, 2012 - AnaSpec, EGT Group

Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing

Boyer has been responsible for guiding business strategies and creating new growth opportunities at OsoBio since 2008 - February 15, 2012 - OSO BioPharmaceuticals Manufacturing, LLC

AnaSpec Introduces SensoLyte® Factor Xa Activity Assays – Industry’s First Fluorimetric Kits

AnaSpec, EGT Group is pleased to announce the release of the industry first fluorimetric Factor Xa activity assays - The SensoLyte® 520 Factor Xa Assay Kit and the SensoLyte® Rh110 Factor Xa Assay Kit. The SensoLyte® 520 Factor Xa Assay Kit employs a FRET (5-FAM/QXL™ 520)... - February 15, 2012 - AnaSpec, EGT Group

GenScript Was the Most Frequently Referred Biology Contract Research Organization by Peer-Reviewed Journal Articles in 2011

GenScript USA Inc., an internationally recognized biology contract research organization (CRO), became the most frequently referred biology CRO in the world by peer-reviewed journal articles in the year 2011. Ever since its inception from 2002, GenScript has been consistently providing biological... - February 03, 2012 - GenScript USA Inc.

AnaSpec Offers Antibodies Against the Hexa-His and GFP Tags

The introduction of tags, whether short peptides (6X-His, DYKDDDDK, c-myc) or proteins (green fluorescent protein – GFP, glutathione-s-transferase – GST) into recombinant proteins aids in the characterization, localization or purification of the recombinant expressed protein.1-3 As a... - February 03, 2012 - AnaSpec, EGT Group

AnaSpec Highlights Calcein AM for Live Cell Staining

Calcein AM (Calcein acetoxymethyl ester), a non-fluorescent, cell permeable compound, converts to the strongly green fluorescent calcein when hydrolyzed by intracellular esterases in live cells.1-2 It is widely used for determining cell viability since the fluorescence intensity of calcein is... - February 02, 2012 - AnaSpec, EGT Group

AnaSpec Highlights Atrial Natriuretic Peptides in GO® Collection

AnaSpec, EGT Group provides a wide range of GO® (catalog) natriuretic peptides for use in research laboratories. Their selection of atrial natriuretic peptides (ANPs) include the biologically active 1-28 amino acid peptide (human/porcine or rat sequences); shorter ANP fragments; and Biotin, FAM... - February 02, 2012 - AnaSpec, EGT Group

AnaSpec Offers Speedy 28-Day Custom Polyclonal Antibody Service

When traditional protocols can take almost 90 days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec is pleased to introduce the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol... - January 25, 2012 - AnaSpec, EGT Group

AnaSpec Introduces SensoLyte® α-Synuclein ELISA Assay

AnaSpec, EGT Group is pleased to announce the release of an ultrasensitive ELISA assay for quantitatingα-synuclein. The SensoLyte® α-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) provides a convenient and quantitative assay for determining α-Synuclein amount in cell and... - January 25, 2012 - AnaSpec, EGT Group

Press Releases 301 - 350 of 715